Znanstveni rad - Prethodno/kratko priopćenje
Advancing rare disease treatment: EMA’s decade-long insights into engineered adoptive cell therapy for rare cancers and orphan designation

Kalland, Maria Elisabeth; Pose-Boirazian, Tomas; Palomo, Gloria Maria; Naumann-Winter, Frauke; Costa, Enrico; Matusevicius, Darius; Duarte, Dinah M.; Malikova, Eva; Vitezić, Dinko; Larsson, Kristina; Magrelli, Armando; Stoyanova-Beninska, Violeta; Mariz, Segundo

Citirajte ovaj rad

Kalland, M. E., Pose Boirazian, T., Palomo, G. M., Naumann Winter, F., Costa, E., Matusevicius, D. ... Mariz, S. (2024). Advancing rare disease treatment: EMA’s decade-long insights into engineered adoptive cell therapy for rare cancers and orphan designation. Gene Therapy. doi: 10.1038/s41434-024-00446-0

Kalland, Maria Elisabeth, et al. "Advancing rare disease treatment: EMA’s decade-long insights into engineered adoptive cell therapy for rare cancers and orphan designation." Gene Therapy, 2024. https://doi.org/10.1038/s41434-024-00446-0

Kalland, Maria Elisabeth, Tomas Pose Boirazian, Gloria Maria Palomo, Frauke Naumann Winter, Enrico Costa, Darius Matusevicius, Dinah M. Duarte, et al. "Advancing rare disease treatment: EMA’s decade-long insights into engineered adoptive cell therapy for rare cancers and orphan designation." Gene Therapy (2024). https://doi.org/10.1038/s41434-024-00446-0

Kalland, M. E., et al. (2024) 'Advancing rare disease treatment: EMA’s decade-long insights into engineered adoptive cell therapy for rare cancers and orphan designation', Gene Therapy. doi: 10.1038/s41434-024-00446-0

Kalland ME, Pose Boirazian T, Palomo GM, Naumann Winter F, Costa E, Matusevicius D, i sur.. Advancing rare disease treatment: EMA’s decade-long insights into engineered adoptive cell therapy for rare cancers and orphan designation. Gene Therapy [Internet]. 14.03.2024. [pristupljeno 23.07.2024.]. doi: 10.1038/s41434-024-00446-0

M. E. Kalland, et al., "Advancing rare disease treatment: EMA’s decade-long insights into engineered adoptive cell therapy for rare cancers and orphan designation", Gene Therapy, Ožujak 2024. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:386946. [Citirano: 23.07.2024.]